Literature DB >> 11063142

Tubulointerstitial nephritis and asymptomatic uveitis.

N Gallego1, R Estepa, F Mampaso, F García-S, A Reche, J Ortuño.   

Abstract

We describe a case of a 10 year-old boy who had fever, weakness, anorexia, weight loss and general malaise. No other remarkable symptoms were present. He had been treated with Aspirin and Ibuprofen. Deterioration of renal function, glucosuria, proteinuria, anemia and increased erythrocyte sedimentation rate were detected. After 7 days observation with no treatment, renal function worsened, glucosuria increased and fever persisted. A renal biopsy was performed and acute tubulointerstitial nephritis was diagnosed. The most common aetiologies of this entity were excluded. An ophthalmologic study revealed bilateral anterior uveitis, therefore the patient was diagnosed as having tubulointerstitial nephritis with uveitis. The child improved on corticosteroid therapy, but uveitis relapsed when treatment was stopped.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11063142

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  4 in total

1.  A case report of tubulo-interstitial nephritis with uveitis (TINU syndrome) and follow-up for one year.

Authors:  Chadi Alkhalil; Fawad A Tanvir; Abdurahman Ahmed; David Lowenthal
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

Review 2.  Acute tubulointerstitial nephritis.

Authors:  Tim Ulinski; Anne-Laure Sellier-Leclerc; Elena Tudorache; Albert Bensman; Bilal Aoun
Journal:  Pediatr Nephrol       Date:  2011-06-03       Impact factor: 3.651

Review 3.  Working Towards an Appropriate Use of Ibuprofen in Children: An Evidence-Based Appraisal.

Authors:  Maurizio de Martino; Alberto Chiarugi; Attilio Boner; Giovanni Montini; Gianluigi L De' Angelis
Journal:  Drugs       Date:  2017-08       Impact factor: 9.546

Review 4.  Acute interstitial nephritis - a reappraisal and update.

Authors:  Rajeev Raghavan; Garabed Eknoyan
Journal:  Clin Nephrol       Date:  2014-09       Impact factor: 0.975

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.